Tuberculosis

Abstract

No AccessNov 2017TuberculosisAuthors/Editors: Barry R. Bloom, Rifat Atun, Ted Cohen, Christopher Dye, Hamish Fraser, Gabriela B. Gomez, Gwen Knight, Megan Murray, Edward Nardell, Eric Rubin, Joshua Salomon, Anna Vassall, Grigory Volchenkov, Richard White, Douglas Wilson, Prashant YadavBarry R. BloomSearch for more papers by this author, Rifat AtunSearch for more papers by this author, Ted CohenSearch for more papers by this author, Christopher DyeSearch for more papers by this author, Hamish FraserSearch for more papers by this author, Gabriela B. GomezSearch for more papers by this author, Gwen KnightSearch for more papers by this author, Megan MurraySearch for more papers by this author, Edward NardellSearch for more papers by this author, Eric RubinSearch for more papers by this author, Joshua SalomonSearch for more papers by this author, Anna VassallSearch for more papers by this author, Grigory VolchenkovSearch for more papers by this author, Richard WhiteSearch for more papers by this author, Douglas WilsonSearch for more papers by this author, Prashant YadavSearch for more papers by this authorhttps://doi.org/10.1596/978-1-4648-0524-0_ch11AboutView ChaptersFull TextPDF (0.5 MB) ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinked In Abstract: Asserts that despite progress in controlling tuberculosis (TB), the decline in incidence has been disappointing, pointing to the need for new strategies and more effective tools. HIV/AIDS is one factor that challenges effective control of TB, especially in Southern African countries. Three key elements are needed to achieve effective TB control and to meet the Sustainable Development Goals: (1) early and accurate diagnosis and drug-sensitivity testing, (2) patient access to and completion of effective treatment, and (3) prevention of progression from latent infection to disease. Prevention requires vaccination and screening of individual at high risk as well as interventions such as air disinfection and the use of masks and respirators in hospitals and other congregate settings. Recommendations stress the need to strengthen health systems in high-burden countries by emphasizing community-based care over hospital care; to improve information systems to ensure patient adherence and manage medication supply chains; and to invest in research to develop the necessary interventions. Fundamentally, current global TB control strategies must undergo revision and receive significant research funding. ReferencesAbel, L, J El-Baghdadi, A A Bousfiha, J L Casanova, and E Schurr 2014. “Human Genetics of Tuberculosis: A Long and Winding Road.” Archive of Philosophical Transitions of the Royal Society of London 12: 369 (1645): 20130428. Google ScholarAbimbola, T O, B J Marston, A A Date, J M Blandford, and N Sangrujee, others. 2012. “Cost-Effectiveness of Tuberculosis Diagnostic Strategies to Reduce Early Mortality among Persons with Advanced HIV Infection Initiating Antiretroviral Therapy.” Journal of Acquired Immune Deficiency Syndromes 60 (1): e1–7. CrossrefGoogle ScholarAbu-Raddad, L J, L Sabatelli, J T Achterberg, J D Sugimoto, and I M Longini Jr. others. 2009. “Epidemiological Benefits of More-Effective Tuberculosis Vaccines, Drugs, and Diagnostics.” Proceedings of the National Academy of Sciences 106 (33): 13980–85. CrossrefGoogle ScholarAchkar, J M and E R Jenny-Avital. 2011. “Incipient and Subclinical Tuberculosis: Defining Early Disease States in the Context of Host Immune Response.” Journal of Infectious Diseases 204 (Suppl 4): S1179–86. CrossrefGoogle ScholarAcuna-Villaorduna, C, A Vassall, G Henostroza, C Seas, and H Guerra, others. 2008. “Cost-Effectiveness Analysis of Introduction of Rapid, Alternative Methods to Identify Multidrug-Resistant Tuberculosis in Middle-Income Countries.” Clinical Infectious Diseases 47 (4): 487–95. CrossrefGoogle ScholarAhuja, S D, D Ashkin, M Avendano, R Banerjee, and M Bauer, others. 2012. “Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-Analysis of 9,153 Patients.” PLoS Medicine 9 (8): e1001300. CrossrefGoogle ScholarAkolo, C, I Adetifa, S Shepperd, and J Volmink 2010. “Treatment of Latent Tuberculosis Infection in HIV Infected Persons.” Cochrane Database of Systematic Reviews 20: CD000171. Google ScholarAlhajri, N, K Alzerwi, H Alsaleh, Bin Yousef, and M Alzaben 2011. “Disseminated (Miliary) Abdominal Tuberculosis after Laparoscopic Gastric Bypass Surgery.” BMJ Case Reports 2011 (May 12): bcr1220103591. Google ScholarAlsdurf, H, P C Hill, A Matteelli, H Getahun, and D Menzies 2016. “The Cascade of Care in Diagnosis and Treatment of Latent Tuberculosis Infection: A Systematic Review and Meta-Analysis.” The Lancet Infectious Diseases 16: 1269–78. CrossrefGoogle ScholarAmoroso, C, B Akimana, B Wise, and H S F Fraser 2010. “Using Electronic Medical Records for HIV Care in Rural Rwanda.” Studies Health Technology and Informatics 160 (Pt. 1):337–41. Google ScholarAnanthakrishnan, R, M Muniyandi, A Jeyaraj, G Palani, and B W C Sathiyasekaran 2012. “Expenditure Pattern for TB Treatment among Patients Registered in an Urban Government DOTS Program in Chennai City, South India.” Tuberculosis Research and Treatment 2012: 747924. CrossrefGoogle ScholarAndersson, D I 2006. “The Biological Cost of Mutational Antibiotic Resistance: Any Practical Conclusions?” Current Opinion in Microbiology 9 (5): 461–65. CrossrefGoogle ScholarAndrews, J R, F Noubary, R P Walensky, R Cerda, and E Losina, others. 2012. “Risk of Progression to Active Tuberculosis Following Reinfection with Mycobacterium tuberculosis.” Clinical Infectious Diseases 54 (6): 784–91. CrossrefGoogle ScholarAnsa, G A, J D Walley, K Siddiqi, and X Wei 2012. “Assessing the Impact of TB/HIV Services Integration on TB Treatment Outcomes and Their Relevance in TB/HIV Monitoring in Ghana.” Infectious Diseases of Poverty 1 (December 24): 13. CrossrefGoogle ScholarArinaminpathy, N, T Cordier-Lassalle, K Lunte, and C Dye 2015. “The Global Drug Facility as an Intervention in the Market for Tuberculosis Drugs.” Bulletin of the World Health Organization 93 (4): 237–48A. CrossrefGoogle ScholarAtun, R 2012. “Health Systems, Systems Thinking and Innovation.” Health Policy and Planning 27 (Suppl 4): iv4–8. CrossrefGoogle ScholarAtun, R and R Coker 2008. “Health Systems and Communicable Disease Control: Emerging Evidence and Lessons from Central and Eastern Europe.” In Health Systems and the Challenge of Communicable Diseases: Experiences from Europe and Latin America, edited by Coker, R., R Atun, and M McKee 193–208. Maidenhead, U.K.: Open University Press. Google ScholarAtun, R, T de Jongh, F Secci, K Ohiri, and O Adeyi 2010. “Integration of Targeted Health Interventions into Health Systems: A Conceptual Framework for Analysis.” Health Policy and Planning 25 (2): 104–11. CrossrefGoogle ScholarAtun, R, F M Knaul, Y Akachi, and J Frenk 2012. “Innovative Financing for Health: What Is Truly Innovative?” The Lancet 380 (9858): 2044–49. CrossrefGoogle ScholarAtun, R, J V Lazarus, W Van Damme, and R Coker 2010. “Interactions between Critical Health System Functions and HIV/AIDS, Tuberculosis, and Malaria Programmes.” Health Policy and Planning 25 (Suppl 1):11–13. CrossrefGoogle ScholarAtun, R, M McKee, F Drobniewski, and R Coker 2005. “Analysis of How the Health Systems Context Shapes Responses to the Control of Human Immunodeficiency Virus: Case-Studies from the Russian Federation.” Bulletin of the World Health Organization 83 (10): 730–38. Google ScholarAtun, R, N Menabde, K Saluvere, M Jesse, and J Habicht 2006. “Introducing a Complex Health Innovation—Primary Health Care Reforms in Estonia (Multimethods Evaluation).” Health Policy 79 (1): 79–91. CrossrefGoogle ScholarAtun, R, Y Samyshkin, F Drobniewski, Y Balabanova, and I Fedorin, others. 2006. “Costs and Outcomes of Tuberculosis Control in the Russian Federation: Retrospective Cohort Analysis.” Health Policy and Planning 21 (5): 353–64. CrossrefGoogle ScholarAtun, R, Y Samyshkin, F Drobniewski, N M Skuratova, and G Gusarova, others. 2005. “Barriers to Sustainable Tuberculosis Control in the Russian Federation Health System.” Bulletin of the World Health Organization 83 (3): 217–23. Google ScholarAtun, R, D E Weil, M Tan Eang, and D Mwakyusa 2010. “Health-System Strengthening and Tuberculosis Control.” The Lancet 375 (9732): 2169–78. CrossrefGoogle ScholarAwofeso, N, I Schelokova, and A Dalhatu 2008. “Training of Front-line Health Workers for Tuberculosis Control: Lessons from Nigeria and Kyrgyzstan.” Human Resources for Health 6 (20): 1–9. Google ScholarAyieko, J, L Abuogi, B Simchowitz, E A Bukusi, and A H Smith, others. 2014. “Efficacy of Isoniazid Prophylactic Therapy in Prevention of Tuberculosis in Children: A Meta-Analysis.” BMC Infectious Diseases 14: 91. CrossrefGoogle ScholarAyles, H and M Muyoyeta 2006. “Isoniazid to Prevent First and Recurrent Episodes of TB.” Tropical Doctor 36 (2): 83–86. CrossrefGoogle ScholarAyles, H, M Muyoyeta, E Du Toit, A Schaap, and S Floyd, others. 2013. “Effect of Household and Community Interventions on the Burden of Tuberculosis in Southern Africa: The ZAMSTAR Community-Randomised Trial.” The Lancet 382 (9899): 1183–94. CrossrefGoogle ScholarAyles, H, A Schaap, A Nota, C Sismanidis, and R Tembwe, others. 2009. “Prevalence of Tuberculosis, HIV, and Respiratory Symptoms in Two Zambian Communities: Implications for Tuberculosis Control in the Era of HIV.” PLoS One 4 (5): e5602. CrossrefGoogle ScholarAziz, A, M Ishaq, and R Akhwand 1985. “Infection Risk of Sputum Positive Tuberculosis Patients to Their Family Contacts with and without Chemotherapy.” Journal of Pakistan Medical Association 35 (8): 249–52. Google ScholarBaker, M A, D Wilson, K Wallengren, A Sandgren, and O Iartchouk, others. 2012. “Polymorphisms in the Gene That Encodes the Iron Transport Protein Ferroportin 1 Influence Susceptibility to Tuberculosis.” Journal of Infectious Diseases 205 (7): 1043–47. CrossrefGoogle ScholarBarrington, J, O Wereko-Brobby, P Ward, W Mwafongo, and S Kungulwe 2010. “SMS for Life: A Pilot Project to Improve Anti-Malarial Drug Supply Management in Rural Tanzania Using Standard Technology.” Malaria Journal 9 (298): 1–9. Google ScholarBarry, C E, H I Boshoff, V Dartois, T Dick, and S Ehrt, others. 2009. “The Spectrum of Latent Tuberculosis: Rethinking the Biology and Intervention Strategies.” Nature Reviews Microbiology 7 (12): 845–55. CrossrefGoogle ScholarBarter, D M, S O Agboola, M B Murray, and T Bärnighausen. 2012. “Tuberculosis and Poverty: The Contribution of Patient Costs in Sub-Saharan Africa—A Systematic Review.” BMC Public Health 12 (November 14): 980. CrossrefGoogle ScholarBassili, A, C Fitzpatrick, E Qadeer, R Fatima, and K Floyd, others. 2013. “A Systematic Review of the Effectiveness of Hospital- and Ambulatory-Based Management of Multidrug-Resistant Tuberculosis.” American Journal of Tropical Medicine and Hygiene 89 (2): 271–80. CrossrefGoogle ScholarBasu, S, J R Andrews, E M Poolman, N R Gandhi, and N S Shah, others. 2007. “Prevention of Nosocomial Transmission of Extensively Drug-Resistant Tuberculosis in Rural South African District Hospitals: An Epidemiological Modelling Study.” The Lancet 370 (9597): 1500–07. CrossrefGoogle ScholarBasu, S and A P Galvani 2008. “The Transmission and Control of XDR TB in South Africa: An Operations Research and Mathematical Modelling Approach.” Epidemiology and Infection 136 (12): 1585–98. CrossrefGoogle ScholarBates, M, J O’Grady, P Mwaba, L Chilukutu, and J Mzyece, others. 2012. “Evaluation of the Burden of Unsuspected Pulmonary Tuberculosis and Co-Morbidity with Non-Communicable Diseases in Sputum Producing Adult Inpatients.” PLoS One 7 (7): e40774. CrossrefGoogle ScholarBates, M N, A Khalakdina, M Pai, L Chang, F Lessa, and K R Smith 2007. “Risk of Tuberculosis from Exposure to Tobacco Smoke: A Systematic Review and Meta-Analysis.” Archives of Internal Medicine 167 (4): 335–42. CrossrefGoogle ScholarBellamy, R, C Ruwende, T Corrah, K P McAdam, and H C Whittle, others. 1998. “Variations in the NRAMP1 Gene and Susceptibility to Tuberculosis in West Africans.” New England Journal of Medicine 338 (10): 640–44. CrossrefGoogle ScholarBhargava, A, A Benedetti, O Oxlade, M Pai, and D Menzies 2014. “Undernutrition and the Incidence of Tuberculosis in India: National and Subnational Estimates of the Population-Attributable Fraction Related to Undernutrition.” National Medical Journal of India 27 (3): 128–33. Google ScholarBilal, N K, C H Herbst, F Zhao, A Soucat, and C Lemiere 2011. “Health Extension Workers in Ethiopia: Improved Access and Coverage for the Rural Poor.” In Yes Africa Can: Success Stories from a Dynamic Continent, edited by Chuhan-Pole, P and M Angwafo 433–43. Washington, DC: World Bank. Google ScholarBinagwaho, A 2013. “Resistant TB: Use the Tools Available.” Nature 494 (7436): 176. CrossrefGoogle ScholarBinagwaho, A, P E Farmer, S Nsanzimana, C Karema, and M Gasana, others. 2014. “Rwanda 20 Years on: Investing in Life.” The Lancet 384 (9940): 371–75. CrossrefGoogle ScholarBIO Ventures for Global Health. 2006. “Tuberculosis Vaccines: The Case for Investment.” Washington, DC: BIO Ventures for Global Health. http://www.bvgh.org/Portals/0/Reports/2006_10_tb_vaccines,_the_case_for_investment.pdf. Google ScholarBlaya, J A, H Fraser, and S F B Holt 2010. “E-Health Technologies Show Promise in Developing Countries.” Health Affairs 29 (2): 244–51. CrossrefGoogle ScholarBlaya, J A, S S Shin, M Yagui, C Contreras, and P Cegielski, others. 2014. “Reducing Communication Delays and Improving Quality of Care with a Tuberculosis Laboratory Information System in Resource Poor Environments: A Cluster Randomized Controlled Trial.” PLoS One 9 (4): e90110. CrossrefGoogle ScholarBlaya, J A, S S Shin, M Yagui, G Yale, and C Z Suarez, others. 2007. “A Web-Based Laboratory Information System to Improve Quality of Care of Tuberculosis Patients in Peru: Functional Requirements, Implementation and Usage Statistics.” BMC Medical Informatics and Decision Making 7: 33. CrossrefGoogle ScholarBloom, B R 1994. Tuberculosis: Pathogenesis, Protection, and Control. Washington, DC: ASM Press. CrossrefGoogle ScholarBloom, B R and R Atun 2016. “Rethinking Global Control of Tuberculosis.” Science Translational Medicine 8 (329): 329. CrossrefGoogle ScholarBloom, B R and P E M Fine 1994. “The BCG Experience: Implications for Future Vaccines against Tuberculosis.” In Tuberculosis: Pathogenesis, Protection, and Control, edited by Bloom, B R531–57. Washington, DC: ASM Press. CrossrefGoogle ScholarBlower, S M, A R Mclean, T C Porco, P M Small, and P C Hopewell, others. 1995. “The Intrinsic Transmission Dynamics of Tuberculosis Epidemics.” Nature Medicine 1 (8): 815–21. CrossrefGoogle ScholarBoehme, C C, P Nabeta, D Hillemann, M P Nicol, and S Shenai, others. 2010. “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.” New England Journal of Medicine 363 (11): 1005–15. CrossrefGoogle ScholarBoehme, C C, M P Nicol, P Nabeta, J S Michael, and E Gotuzzo, others. 2011. “Feasibility, Diagnostic Accuracy, and Effectiveness of Decentralised Use of the Xpert MTB/RIF Test for Diagnosis of Tuberculosis and Multidrug Resistance: A Multicentre Implementation Study.” The Lancet 377 (9776): 1495–505. CrossrefGoogle ScholarBoelaert, J R, S J Vandecasteele, R Appelberg, and V R Gordeuk 2007. “The Effect of the Host’s Iron Status on Tuberculosis.” Journal of Infectious Diseases 195 (12): 1745–53. CrossrefGoogle ScholarBorrell, S and S Gagneux 2011. “Strain Diversity, Epistasis, and the Evolution of Drug Resistance in Mycobacterium tuberculosis.” Clinical Microbiology and Infection 17 (6): 815–20. CrossrefGoogle ScholarBrennan, M J and J Thole 2012. “Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade.” Tuberculosis 92 (Suppl 1): S6–13. CrossrefGoogle ScholarBrouwer, J A, M J Boeree, P Kager, C M Varkevisser, and A D Harries 1998. “Traditional Healers and Pulmonary Tuberculosis in Malawi.” International Journal of Tuberculosis and Lung Disease 2 (3): 231–34. Google ScholarBrust, J C, N S Shah, M Scott, K Chaiyachati, and M Lygizos, others. 2012. “Integrated, Home-Based Treatment for MDR-TB and HIV in Rural South Africa: An Alternate Model of Care.” International Journal of Tuberculosis and Lung Disease 16 (8): 998–1004. CrossrefGoogle ScholarBuchan, J and M R Poz Dal. 2002. “Skill Mix in the Health Care Workforce: Reviewing the Evidence.” Bulletin of the World Health Organization 80 (7): 575–80. Google ScholarBustamante, J, S Boisson-Dupuis, L Abel, and J L Casanova 2014. “Mendelian Susceptibility to Mycobacterial Disease: Genetic, Immunological, and Clinical Features of Inborn Errors of IFN-y Immunity.” Seminars in Immunology 26 (6): 454–70. CrossrefGoogle ScholarCaminero, J 2003. “Is the DOTS Strategy Sufficient to Achieve Tuberculosis Control in Low- and Middle-Income Countries? 1. Need for Interventions in Universities and Medical Schools [Unresolved Issues].” International Journal of Tuberculosis and Lung Disease 7 (6): 509–15. Google ScholarCar, J, T Paljärvi, M Car, A Kazeem, and A Majeed, others. 2012. “Negative Health System Effects of Global Fund’s Investments in AIDS, Tuberculosis. and Malaria from 2002 to 2009: Systematic Review.” Journal of the Royal Society of Medicine Short Reports 3 (10): 70. Google ScholarCauthen, G M, A Pio, and H G ten Dam 2002. “Annual Risk of Tuberculosis Infection.” Bulletin of the World Health Organization 80 (6): 503–11. Google ScholarCavalcante, S, B Durovni, G L Barnes, F B A Souza, and R F Silva, others. 2010. “Community-Randomized Trial of Enhanced DOTS for Tuberculosis Control in Rio de Janeiro, Brazil.” International Journal of Tuberculosis and Lung Disease 14 (2): 203. Google ScholarCavalcante, S, E Soares, A G F Pacheco, R E Chaisson, and B Durovni, others. 2007. “Community DOT for Tuberculosis in a Brazilian Favela: Comparison with a Clinic Model.” International Journal of Tuberculosis and Lung Disease 11 (5): 544–49. Google ScholarCegielski, J P, L Arab, and J Cornoni-Huntley. 2012. “Nutritional Risk Factors for Tuberculosis among Adults in the United States, 1971–1992.” American Journal of Epidemiology 176 (5): 409–22. CrossrefGoogle ScholarChadha, V, P Kumar, P S Jagannatha, P S Vaidyanathan, and K P Unnikrishnan 2005. “Average Annual Risk of Tuberculous Infection in India.” International Journal of Tuberculosis and Lung Disease 9 (1): 116–18. Google ScholarChahal, J S, O F Khan, C L Cooper, J S McPartlan, and J K Tsosie, others. 2016. “Dendrimer-RNA Nanoparticles Generate Protective Immunity against Lethal Ebola, H1N1 Influenza, and Toxoplasma gondii Challenges with a Single Dose.” Proceedings of the National Academy of Sciences 113 (29): E4133–42. CrossrefGoogle ScholarChakraborty, S, T Gruber, C E Barry, H I Boshoff, and K Y Rhee 2013. “Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis.” Science 339 (6115): 88–91. CrossrefGoogle ScholarChan, P C, C H Yang, L Y Chang, K F Wang, and Y C Kuo, others. 2013. “Lower Prevalence of Tuberculosis Infection in BCG Vaccinees: A Cross-Sectional Study in Adult Prison Inmates.” Thorax 68 (3): 263–68. CrossrefGoogle ScholarChang, K, W Lu, J Wang, K Zhang, and S Jia, others. 2012. “Rapid and Effective Diagnosis of Tuberculosis and Rifampicin Resistance with Xpert MTB/RIF Assay: A Meta-Analysis.” Journal of Infection 64 (6): 580–88. CrossrefGoogle ScholarChee, C, M Teleman, I C Boudville, and Y T Wang 2005. “Contact Screening and Latent TB Infection Treatment in Singapore Correctional Facilities.” International Journal of Tuberculosis and Lung Disease 9 (11): 1248–52. Google ScholarChimusa, E R, N Zaitlen, M Daya, M Moller, and P D van Helden, others. 2014. “Genome-Wide Association Study of Ancestry-Specific TB Risk in the South African Coloured Population.” Human Molecular Genetics 23 (3): 796–809. CrossrefGoogle ScholarChoi, I J, Y W Kim, H S Lee, K W Ryu, and H M Yoon, others. 2015. “Risk Factors for TB in Patients with Early Gastric Cancer: Is Gastrectomy a Significant Risk Factor for TB?” Chest 148 (3): 774–83. CrossrefGoogle ScholarChurchyard, G, K Fielding, J Lewis, L Coetzee, and E Corbett, others. 2012. “Community-Wide Isoniazid Preventive Therapy Does Not Improve TB Control among Gold Miners: the Thibela TB Study, South Africa.” Paper presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, March 5–8. Google ScholarChurchyard, G, K Fielding, J Lewis, L Coetzee, and E Corbett, others. 2014. “A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control.” New England Journal of Medicine 370 (17): 301–10. CrossrefGoogle ScholarCobelens, F, S van Kampen, E Ochodo, R Atun, and C Lienhardt 2012. “Research on Implementation of Interventions in Tuberculosis Control in Low- and Middle-Income Countries: A Systematic Review.” PLoS Medicine 9 (12): e1001358. CrossrefGoogle ScholarCohen, T, C Colijn, A Wright, M Zignol, and A Pym, others. 2008. “Challenges in Estimating the Total Burden of Drug-Resistant Tuberculosis.” American Journal of Respiratory and Critical Care Medicine 177 (12): 1302–06. CrossrefGoogle ScholarCohen, T, H E Jenkins, C Lu, M McLaughlin, and K Floyd, others. 2014. “On the Spread and Control of MDR-TB Epidemics: An Examination of Trends in Anti-Tuberculosis Drug Resistance Surveillance Data.” Drug Resistance Updates 17 (4–6):105–23. CrossrefGoogle ScholarCoker, R, R A Atun, and M McKee 2004. “Health-Care System Frailties and Public Health Control of Communicable Disease on the European Union’s New Eastern Border.” The Lancet 363 (9418): 1389–92. CrossrefGoogle ScholarCoker, R, B Dimitrova, F Drobniewski, Y Samyshkin, and J Pomerleau, others. 2005. “Health System Frailties in Tuberculosis Service Provision in Russia: An Analysis through the Lens of Formal Nutritional Support.” Public Health 119 (9): 837–43. CrossrefGoogle ScholarColijn, C, A Brandes, J Zucker, D S Lun, and B Weiner, others. 2009. “Interpreting Expression Data with Metabolic Flux Models: Predicting Mycobacterium tuberculosis Mycolic Acid Production.” PLoS Computational Biology 5 (8): e1000489. CrossrefGoogle ScholarComstock, G W, C Baum, and D. E Snider Jr.,. 1979. “Isoniazid Prophylaxis among Alaskan Eskimos: A Final Report of the Bethel Isoniazid Studies.” American Review of Respiratory Disease 119 (5): 827–30. Google ScholarConnor, S, K Foley, R Harding, and E Jaramillo 2012. “Declaration on Palliative Care and MDR/XDR-TB.” International Journal of Tuberculosis and Lung Disease 16 (6): 712–13. CrossrefGoogle ScholarCorbett, E L, T Bandason, Y B Cheung, B Makamure, and E Dauya, others. 2009. “Prevalent Infectious Tuberculosis in Harare, Zimbabwe: Burden, Risk Factors and Implications for Control.” International Journal of Tuberculosis and Lung Disease 13 (10): 1231. Google ScholarCorbett, E L, T Bandason, T Duong, E Dauya, and B Makamure, others. 2010. “Comparison of Two Active Case-Finding Strategies for Community-Based Diagnosis of Symptomatic Smear-Positive Tuberculosis and Control of Infectious Tuberculosis in Harare, Zimbabwe (DETECTB): A Cluster-Randomised Trial.” The Lancet 376 (9748): 1244–53. CrossrefGoogle ScholarCorbett, E L, S Charalambous, V M Moloi, K Fielding, and A D Grant, others. 2004. “Human Immunodeficiency Virus and the Prevalence of Undiagnosed Tuberculosis in African Gold Miners.” American Journal of Respiratory and Critical Care Medicine 170 (6): 673–79. CrossrefGoogle ScholarCorbett, E L, G J Churchyard, T C Clayton, B G Williams, and D Mulder, others. 2000. “HIV Infection and Silicosis: The Impact of Two Potent Risk Factors on the Incidence of Mycobacterial Disease in South African Miners.” AIDS 14 (17): 2759–68. CrossrefGoogle ScholarCorbett, E L, B Marston, and G J Churchyard DeK. M Cock. 2006. “Tuberculosis in Sub-Saharan Africa: Opportunities, Challenges, and Change in the Era of Antiretroviral Treatment.” The Lancet 367 (9514): 926–37. CrossrefGoogle ScholarCorbett, E L, C J Watt, N Walker, D Maher, and B G Williams, others. 2003. “The Growing Burden of Tuberculosis: Global Trends and Interactions with the HIV Epidemic.” Archives of Internal Medicine 163 (9): 1009–21. CrossrefGoogle ScholarCoronado, V G, C M Beck-Sague, M D Hutton, B J Davis, and P Nicholas, others. 1993. “Transmission of Multidrug-Resistant Mycobacterium tuberculosis among Persons with Human Immunodeficiency Virus Infection in an Urban Hospital: Epidemiologic and Restriction Fragment Length Polymorphism Analysis.” Journal of Infectious Diseases 168 (4): 1052–55. CrossrefGoogle ScholarCox, E and K Laessig 2014. “FDA Approval of Bedaquiline—the Benefit-Risk Balance for Drug-Resistant Tuberculosis.” New England Journal of Medicine 371 (8): 689–91. CrossrefGoogle ScholarCreswell, J, M Raviglione, S Ottmani, G B Migliori, and M W Uplekar, others. 2011. “Tuberculosis and Noncommunicable Diseases: Neglected Links and Missed Opportunities.” European Respiratory Journal 37 (5): 1269–82. CrossrefGoogle ScholarCritchley, J A, F Young, L Orton, and P Garner 2013. “Corticosteroids for Prevention of Mortality in People with Tuberculosis: A Systematic Review and Meta-Analysis.” The Lancet Infectious Diseases 13 (3): 223–37. CrossrefGoogle ScholarCuevas, L E, N Al-Sonboli, L Lawson, M A Yassin, and I Arbide, others. 2011. “LED Fluorescence Microscopy for the Diagnosis of Pulmonary Tuberculosis: A Multi-Country Cross-Sectional Evaluation.” PLoS Medicine 8(7): e1001057. CrossrefGoogle ScholarDas, J, A Kwan, B Daniels, S Satyanarayana, and R Subbaraman, others. 2015. “Use of Standardised Patients to Assess Quality of Tuberculosis Care: A Pilot, Cross-Sectional Study.” The Lancet Infectious Diseases 15 (11): 1305–13. CrossrefGoogle Scholarda Silva, R C, L Segat, H L da Cruz, H C Schindler, and L M Montenegro, others. 2014. “Association of CD209 and CD209L Polymorphisms with Tuberculosis Infection in a Northeastern Brazilian Population.” Molecular Biology Reports 41 (8): 5449–57. CrossrefGoogle ScholarDatiko, D G and B Lindtjørn. 2009. “Health Extension Workers Improve Tuberculosis Case Detection and Treatment Success in Southern Ethiopia: A Community Randomized Trial.” PLoS One 4(5): e5443. Google ScholarDatiko, D G and B Lindtjørn. 2010. “Cost and Cost-Effectiveness of Smear Positive Tuberculosis Treatment by Health Extension Workers in Southern Ethiopia: A Community Randomized Trial.” PLoS One 5 (2): e9158. CrossrefGoogle ScholarDella Mea, V 1999. “Internet Electronic Mail: A Tool for Low-Cost Telemedicine.” Journal of Telemedicine and Telecare 5 (2): 84–89. CrossrefGoogle ScholarDeLuca, A, R E Chaisson, and N A Martinson 2009. “Intensified Case Finding for Tuberculosis in Prevention of Mother to Child Transmission Programs; a Simple and Potentially Vital Addition for Maternal and Child Health.” Journal of Acquired Immune Deficiency Syndromes 50 (2): 196–99. CrossrefGoogle Scholarden Boon, S, A Matteelli, N Ford, and H Getahun 2016. “Continuous Isoniazid for the Treatment of Latent Tuberculosis Infection in People Living with HIV.” AIDS 30 (5): 797–801. CrossrefGoogle Scholarden Boon, S, S W P van Lill, M W Borgdorff, D A Enarson, and S Verver, others. 2007. “High Prevalence of Tuberculosis in Previously Treated Patients, Cape Town, South Africa.” Emerging Infectious Diseases 13 (8): 1189. CrossrefGoogle ScholarDetjen, A K, A R DiNardo, J Leyden, K R Steingart, and D Menzies, others. 2015. “Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in Children: A Systematic Review and Meta-Analysis.” The Lancet Respiratory Medicine 3 (6): 451–61. CrossrefGoogle Scholarde Vries, G, R Aldridge, J A Cayla, W H Haas, and A Sandgren, others. 2014. “Epidemiology of Tuberculosis in Big Cities of the European Union and European Economic Area Countries.” Eurosurveillance 19 (9): pii=20726. CrossrefGoogle ScholarDharmadhikari, A S, M Mphahlele, A Stoltz, K Venter, and R Mathebula, others. 2012. “Surgical Face Masks Worn by Patients with Multidrug-Resistant Tuberculosis: Impact on Infectivity of Air on a Hospital Ward.” American Journal of Respiratory and Critical Care Medicine 185 (10): 1104–19. CrossrefGoogle ScholarDharmadhikari, A S, M Mphahlele, K Venter, A Stoltz, and R Mathebula, others. 2014. “Rapid Impact of Effective Treatment on Transmission of Multidrug-Resistant Tuberculosis.” International Journal of Tuberculosis and Lung Disease 18 (9): 1019–25. CrossrefGoogle ScholarDheda, K, T Gumbo, N R Gandhi, M Murray, and G Theron, others. 2014. “Global Control of Tuberculosis: From Extensively Drug-Resistant to Untreatable Tuberculosis.” The Lancet Respiratory Medicine 2 (4): 321–38. CrossrefGoogle ScholarDiacon, A H, R Dawson, M Hanekom, K Narunsky, and S J Maritz, others. 2010. “Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients.” Antimicrobial Agents and Chemotheraphy 54 (8): 3402–07. CrossrefGoogle ScholarDiacon, A H, R Dawson, F von Groote-Bidlingmaier, G Symons, and A Venter, others. 2012. “14-Day Bactericidal Activity of PA-824, Bedaquiline, Pyrazinamide, and Moxifloxacin Combinations: A Randomised Trial.” The Lancet 380 (9846): 986–93. CrossrefGoogle ScholarDiacon, A H, P R Donald, A Pym, M Grobusch, and R F Patientia, others. 2012. “Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance.” Antimicrobial Agents and Chemotheraphy 56 (6): 3271–76. CrossrefGoogle ScholarDiacon, A H, A Pym, M P Grobusch, J M de los Rios, and E Gotuzzo, others. 2014. “Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline.” New England Journal of Medicine 371 (8): 723–32. CrossrefGoogle ScholarDi